Edwina N. Scott

Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice

Hong Cai, Edwina N. Scott, Abeer Othman A. Kholghi et al. · Science Translational Medicine · 2015 · 175 citations · Full text

Chemoprevention Strategy, Oxidative Stress, Oncology +17

Safety and tolerability of the poly(ADP-ribose) polymerase (PARP) inhibitor, olaparib (AZD2281) in combination with topotecan for the treatment of patients with advanced solid tumors: a phase I study

Jens Samol, Malcolm Ranson, Edwina N. Scott et al. · Investigational New Drugs · 2011 · 154 citations

Medicine, Cancer Management, Pharmacology +8

Prolonged Biologically Active Colonic Tissue Levels of Curcumin Achieved After Oral Administration—A Clinical Pilot Study Including Assessment of Patient Acceptability

Glen R.B. Irving, Lynne Howells, Stewart Sale et al. · Cancer Prevention Research · 2012 · 109 citations · Full text

Surgical bypass vs. endoscopic stenting for pancreatic ductal adenocarcinoma

Edwina N. Scott, Giuseppe Garcea, H. Doucas et al. · HPB · 2009 · 40 citations · Full text

A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI™), in patients with advanced solid tumours

Edwina N. Scott, Anne Thomas, L Rhoda Molife et al. · Cancer Chemotherapy and Pharmacology · 2009 · 34 citations

Oncology, Medicine, Advanced Solid Tumours +8